MedPath

A RANDOMISED CONTROL STUDY COMPARING THE PLACEMENT OF 2 DRAINS, THAT IS, IN AXILLA AND PECTORAL SKIN FLAP VERSUS SINGLE DRAIN IN AXILLA POST MODIFIED RADICAL MASTECTOMY IN PREVENTING POST OPERATIVE SEROMA AND LOCAL COMPLOCATIONS

Phase 2
Not yet recruiting
Conditions
Malignant neoplasms of breast,
Registration Number
CTRI/2023/02/049897
Lead Sponsor
DR DEEPALI SHETTY
Brief Summary

Breast cancer has seen a rapid rise inincidence, becoming the leading cause of global cancer incidence in 2020.Choice of treatment is Modified Radical Mastectomy (MRM). Most commonlyencountered complication of MRM is formation of seroma, which can be preventedby the use of closed suction drainage system, preferable active suctiondrainage.

 ThisProspective Randomised controlled study attempts to compare the efficacy andthe morbidities associated with use of combined axillary and pectoral drainversus single axillary drainage post modified radical mastectomy.

Objectives:Assessing the incidence of seroma formation, post op wound infection, durationof drain insitu, drain output and length of hospital stay

 Womenwith histologically proven breast cancer, stage 1,2 3 not undergoingneoadjuvant therapy undergoing MRM, will be included in the study and will berandomized into 2 groups using envelope method, Group A (single axillary drain)and Group B (combined axillary and pectoral drainage), with 78 patients in eachgroup (total sample size 156)

 Standardizedoperative procedure and post-operative course will be followed in all patientsin both groups in drain emptying and dressing

Patient will be followed up postoperativelyto evaluate drain output, incidence of surgical site infection, flap necrosis,seroma formation (clinically and quantified with ultrasonography), timing ofdrain removal and total duration of hospital stay.

 Data willcollected and analyzed with SPSS version 28.

The quantitative data will be reported as meanand standard deviation. Differences between means will be tested with Student’st-test and the incidence of seroma, flap necrosis and wound infection will bereported as number and percentages and Fisher’s exact test/ Chi square testwill be employed.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
156
Inclusion Criteria

Histologically proven Breast cancer patients of Stage 1 and II undergoing Modified Radical Mastectomy Stage III breast cancer not receiving neo-adjuvant treatment undergoing Modified Radical Mastectomy.

Exclusion Criteria

Recurrent breast cancer Patients receiving Neoadjuvant chemotherapy or Radiotherapy Metastatic breast cancer.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess occurrence of post-operative seroma with use of single versus double drainage in modified radical mastectomy, in patients with histologically proven breast cancer not undergoing neoadjuvant therapy1ST, 3RD, 5TH, 7TH, 9TH DAY POST OPERATIVELY
Secondary Outcome Measures
NameTimeMethod
Post-operative painOccurrence of Flap necrosis

Trial Locations

Locations (1)

AIIMS NAGPUR

🇮🇳

Nagpur, MAHARASHTRA, India

AIIMS NAGPUR
🇮🇳Nagpur, MAHARASHTRA, India
DR DEEPALI J SHETTY
Principal investigator
9008811623
djshetty97@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.